A DNA Aptamer That Inhibits the Aberrant Signaling of Fibroblast Growth Factor Receptor in Cancer Cells-Reference-Cited by-同舟云学术

A DNA Aptamer That Inhibits the Aberrant Signaling of Fibroblast Growth Factor Receptor in Cancer Cells

Published:2021-04-08 Issue:5 Volume:1 Page:578-585
ISSN:2691-3704
Container-title:JACS Au
language:en
Short-container-title:JACS Au

Author:

Eguchi Akihiro,Ueki Ayaka,Hoshiyama Junya,Kuwata Keiko¹,Chikaoka Yoko²,Kawamura Takeshi²,Nagatoishi Satoru³^ORCID,Tsumoto Kouhei³^ORCID,Ueki Ryosuke^ORCID,Sando Shinsuke^ORCID

Affiliation:

1. Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan

2. Proteomics Laboratory, Isotope Science Center, The University of Tokyo, 2-11-16, Yayoi, Bunkyo-Ku, Tokyo 113-0032, Japan

3. The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Asahi Glass Foundation

Adaptable and Seamless Technology Transfer Program through Target-Driven R and D

Japan Society for the Promotion of Science

Noguchi Institute

Publisher

American Chemical Society (ACS)

Subject

General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jacsau.0c00121

Reference46 articles.

1. GROWTH FACTOR RECEPTOR TYROSINE KINASES

2. Platelet-derived growth factor receptor signals.

3. Epidermal growth factor receptor signaling

4. ErbB-2 Amplification Inhibits Down-regulation and Induces Constitutive Activation of Both ErbB-2 and Epidermal Growth Factor Receptors

5. RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and Survival

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA-Programed Plasmon Rulers Decrypt Single-Receptor Dimerization on Cell Membrane;Journal of the American Chemical Society;2023-01-09

2. Apt-clean: aptamer-mediated cleavage of extracellular antigens for the inhibition of membrane protein functions;Biomaterials Science;2023

3. Therapeutic Potential of Aptamer–Protein Interactions;ACS Pharmacology & Translational Science;2022-11-04

4. The emerging potential of Aptamers as therapeutic agents in infection and inflammation;Pharmacology & Therapeutics;2022-10

5. Rationally Screened and Designed ABCG2-Binding Aptamers for Targeting Cancer Stem Cells and Reversing Multidrug Resistance;Analytical Chemistry;2022-05-11